MPGES-1 INHIBITOR FOR THE TREATMENT OF OSTEOARTHRITIS PAIN

The present invention relates to a microsomal prostaglandin E synthases-1 ("mPGES- 1") inhibitor for the treatment of osteoarthritis pain in a subject. For example, the present invention relates to a method of treating moderate osteoarthritis pain in a subject in need thereof by orally adm...

Full description

Saved in:
Bibliographic Details
Main Authors SANT, Sumit, GUDI, Girish, MENON, Vinu C A, TANDON, Monika, KHAIRATKAR-JOSHI, Neelima, TALLURI, Ravi
Format Patent
LanguageEnglish
French
Published 28.03.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a microsomal prostaglandin E synthases-1 ("mPGES- 1") inhibitor for the treatment of osteoarthritis pain in a subject. For example, the present invention relates to a method of treating moderate osteoarthritis pain in a subject in need thereof by orally administering to the subject a substituted triazolone compound as a mPGES-1 inhibitor. The present invention also relates to pharmaceutical compositions comprising the mPGES-1 inhibitor, and to processes for preparing such pharmaceutical compositions. La présente invention concerne un inhibiteur de la prostaglandine E synthase-1 microsomale ("mPGES-1") pour le traitement de la douleur de l'arthrose chez un sujet. Par exemple, la présente invention concerne une méthode de traitement de la douleur modérée d'arthrose chez un sujet en ayant besoin par administration par voie orale au sujet d'un composé triazolone substitué en tant qu'inhibiteur de mPGES-1. La présente invention concerne également des compositions pharmaceutiques comprenant l'inhibiteur de mPGES-1, et des procédés de préparation de telles compositions pharmaceutiques.
Bibliography:Application Number: WO2018IB57244